STOCK TITAN

NewAmsterdam Pharma: RA Capital reports 9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

NewAmsterdam Pharma Co N.V. (NAMS) is the issuer in an amended Schedule 13G reporting that RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah and RA Capital Healthcare Fund, L.P. each listed 12,207,198 ordinary shares as beneficially owned, with shared voting and dispositive power over that amount, as of September 30, 2026. The ownership discussion gives a percentage of 9.99%, based on 119,537,169 ordinary shares outstanding as of August 3, 2026, and gives effect to warrants exercisable within 60 days.

The Fund directly holds 9,550,191 ordinary shares, plus ordinary share warrants for 333,333 shares and pre-funded warrants for 4,587,634 shares. Both warrant types restrict exercise where it would cause the Fund, its affiliates and other attribution parties to own more than 9.99% of outstanding ordinary shares. The report says the Fund is currently prohibited from exercising a portion of the warrants to the extent exercise would result in beneficial ownership of more than 12,207,198 ordinary shares.

Reported beneficial ownership 12,207,198 ordinary shares Each of the four reporting persons listed this amount as of September 30, 2026.
Ownership percentage 9.99% Narrative percentage as of September 30, 2026; based on 119,537,169 ordinary shares outstanding as of August 3, 2026, with effect given to warrants exercisable within 60 days.
Cover-page percentage 9.9% Rounded down due to EDGAR filing-system field limitations.
Ordinary shares directly held by the Fund 9,550,191 ordinary shares Held directly by RA Capital Healthcare Fund, L.P.
Ordinary share warrants 333,333 warrants for 333,333 ordinary shares Directly held by RA Capital Healthcare Fund, L.P.
Pre-funded warrants 4,587,634 warrants for 4,587,634 ordinary shares Directly held by RA Capital Healthcare Fund, L.P.
Ordinary shares outstanding 119,537,169 ordinary shares Outstanding as of August 3, 2026; used as the ownership-percentage denominator.
Beneficial Ownership Blockers regulatory
"the provision called the Beneficial Ownership Blockers"
Pre-Funded Warrants financial
"4,587,634 pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Section 13(d) regulatory
"for purposes of Section 13(d) of the Act"
A Section 13(d) filing is a public disclosure required under U.S. securities law when a person or group acquires more than 5% of a company’s registered equity and may influence control. The filer must report who owns the shares, how they were acquired, and any plans or intentions for the company, so the market and other shareholders can see if a large buyer is attempting a takeover or other strategic move. Think of it like a formal announcement that someone has crossed a threshold and is showing their hand.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NAMS shares did RA Capital and the other reporting persons report?

Each of the four reporting persons listed 12,207,198 ordinary shares as beneficially owned as of September 30, 2026. The cover pages also report shared voting and dispositive power over that amount.

What notice must the NAMS reporting fund give to revoke its delegation to RA Capital?

RA Capital Healthcare Fund, L.P. delegated sole voting and disposition power over its portfolio securities to RA Capital Management, L.P. and may not revoke that delegation on less than 61 days’ notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





N62509109

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RA Capital Management, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By Peter Kolchinsky, Authorized Signatory
Date:11/16/2026
Peter Kolchinsky
Signature:/s/ Peter Kolchinsky
Name/Title:Peter Kolchinsky
Date:11/16/2026
Rajeev Shah
Signature:/s/ Rajeev Shah
Name/Title:Rajeev Shah
Date:11/16/2026
RA Capital Healthcare Fund, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on May 15, 2025).

Keep reading